Pre-seed through Series B

Price by who consumes the product

You sell an AI product from a pre-seed to Series B company. You must choose between seat and outcome pricing. Seat counts collapse when agents do the work.

Options

Seat-based pricing per human user

Outcome or usage pricing per job completed

Hybrid platform fee plus usage

What mattered

What was done

Founders in the sessions kept seats where humans consume, sold outcomes where agents do the work, and moved toward a platform fee plus usage as the default.

ClaimIf the end consumer of the product is a human, seats survive; if it is an agent, sell outcomes or usage.

FAQ

Which stage does this apply to?
Pre-seed through Series B.
Where does this come from?
It comes from VEN (Venture Executive Network) founder sessions, and we anonymize the speakers.

VEN convenes small peer sessions around decisions like this one.